Ethylene Glycol

Ethylene Glycol

SCHEMBL524375

CC(COC(=O)c1ccccc1)OC(=O)c1ccccc1.OCCO

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.62
ADRB2 P07550 2/20 0.54
ADRB1 P08588 2/20 0.54
ADRB3 P13945 2/20 0.54
PRKCA P17252 1/20 0.54
LMNA P02545 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
POLB P06746 1/20 0.49
SCN1A P35498 1/20 0.49
SCN2A Q99250 1/20 0.49
SCN3A Q9NY46 1/20 0.49
TSHR P16473 3/20 0.49
NPC1 O15118 1/20 0.48
TDP1 Q9NUW8 2/20 0.47
TP53 P04637 1/20 0.47
MAPT P10636 1/20 0.46
PDCD1 Q15116 1/20 0.46
CD274 Q9NZQ7 1/20 0.46
MAPK1 P28482 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzil SCHEMBL11690264 0.95 ALDH1A1 (0.57) ALDH1A1ADRB2ADRB1ADRB3PRKCA
SCHEMBL227395 0.95 ALDH1A1 (0.62) ALDH1A1ADRB2ADRB1ADRB3PRKCA
SCHEMBL16019900 0.95 ALDH1A1 (0.62) ALDH1A1ADRB2ADRB1ADRB3PRKCA
Propylene Glycol SCHEMBL4197713 0.94 ALDH1A1 (0.59) ALDH1A1ADRB2ADRB1ADRB3PRKCA
SCHEMBL2618310 0.93 ALDH1A1 (0.61) ALDH1A1ADRB2ADRB1ADRB3PRKCA
SCHEMBL16217637 0.93 ALDH1A1 (0.61) ALDH1A1ADRB2ADRB1ADRB3PRKCA
SCHEMBL12559135 0.93 ALDH1A1 (0.61) ALDH1A1ADRB2ADRB1ADRB3PRKCA
Ethylene SCHEMBL11340964 0.92 ALDH1A1 (0.59) ALDH1A1ADRB2ADRB1ADRB3PRKCA
Propylene Glycol SCHEMBL4188265 0.91 ALDH1A1 (0.58) ALDH1A1ADRB2ADRB1ADRB3PRKCA
Propylene Glycol SCHEMBL4197718 0.91 ALDH1A1 (0.58) ALDH1A1ADRB2ADRB1ADRB3PRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118046691-A Acrylic acid type water-soluble pattern film, preparation method and application thereof 孙琇芳 2024-05-17 CN claimed
CN-106883808-B Adhesive, preparation method thereof and electrophoretic display 广州奥翼电子科技股份有限公司 2021-02-12 CN claimed
CN-106967379-B Electrophoretic display device, adhesive and preparation method thereof 广州奥翼电子科技股份有限公司 2020-12-08 CN claimed
US-20160194455-A1 Silicone Elastomer Gels and Related Hydrosilylation Processes ALZO INT INC (US) 2016-07-07 US claimed
US-20150274972-A1 ENHANCED WATER AND TRANSFER RESISTANT FILM FORMING ALZO INTERNATIONAL, INC. (US) 2015-10-01 US claimed
EP-2906614-A1 ENHANCED WATER AND TRANSFER RESISTANT FILM FORMING Alzo International, Inc. (US) 2015-08-19 EP claimed
US-9109156-B2 Chemiluminescent system IMPERIAL TOY LLC (US) 2015-08-18 US claimed
WO-2015048228-A2 IMPROVED SILICONE ELASTOMER GELS AND RELATED HYDROSILYLATION PROCESSES ALZO INTERNATIONAL, INC. (US) 2015-04-02 WO claimed
US-20140166949-A1 Chemiluminescent system GREAT ROCK CAPITAL PARTNERS MANAGEMENT, LLC, AS AGENT 2014-06-19 US claimed
US-20130168620-A1 Chemiluminescent system Maggilume, LLC 2013-07-04 US claimed
WO-2013102068-A1 CHEMILUMINESCENT SYSTEM MAGGILUME (US) 2013-07-04 WO claimed
US-20100028779-A1 Porous Polyimide Membrane, Battery Separator, Battery, and Method BYD CO., LTD. (CN) 2010-02-04 US claimed
US-20080233067-A1 Method Of Making Enhanced Efficacy Antiperspirant Actives COLGATE-PALMOLIVE COMPANY (US) 2008-09-25 US claimed
US-6812254-B1 TRANSDERMAL APPLICATION OF ENCAPSULATED CAPSAICIN, COLLOIDAL OATMEAL OR DIPOTASSIUM GLYCYRRHIZINATE, LAURYL MENTHYL ESTERS OF AMINO ACID; MINIMIZATION OF BURNING AND DISCOMFORT MEDICAL MERCHANDISING INC. 2004-11-02 US claimed
US-20040077747-A1 Antimicrobial superfinish and method of making MICROBAN PRODUCTS COMPANY 2004-04-22 US claimed
EP-1292274-A2 METHOD OF MAKING ENHANCED EFFICACY ANTIPERSPIRANT ACTIVES Colgate-Palmolive Company (US) 2003-03-19 EP claimed
US-20030003069-A1 Multiple phase foaming personal cleansing products ALZO INTERNATIONAL, INC. 2003-01-02 US claimed
WO-2002064668-A1 ANTIMICROBIAL SUPERFINISH AND METHOD OF MAKING MICROBAN PRODUCTS COMPANY (US) 2002-08-22 WO claimed
WO-2001097768-A2 METHOD OF MAKING ENHANCED EFFICACY ANTIPERSPIRANT ACTIVES COLGATE-PALMOLIVE COMPANY (US) 2001-12-27 WO claimed
US-4656214-A DIESTERS EXXON RESEARCH & ENGINEERING CO. (US) 1987-04-07 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150274972-A1 ENHANCED WATER AND TRANSFER RESISTANT FILM FORMING CUTA, TRRAP, LCP1 ALDH1A1 3740/4885ADRB2 4856/4885ADRB1 4871/4885
US-20160194455-A1 Silicone Elastomer Gels and Related Hydrosilylation Processes ITCH, MMS19, STS ALDH1A1 1935/4885ADRB2 4277/4885ADRB1 4516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.